Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
silk	O
/	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Fever	O
x1	O
day	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
hx	O
of	O
a	O
rare	O
myelodysplastic	O
disorder	O
followed	O
by	O
Dr.	O
___	O
presenting	O
with	O
fever	O
after	O
dental	O
procedure.	O
Pt	O
describes	O
presenting	O
to	O
Dr.	O
___	O
office	O
on	O
___	O
prior	O
to	O
scheduled	O
dental	O
procedure	O
(taking	O
molds	O
in	O
preparation	O
for	O
post	O
placement)	O
for	O
pre-procedure	O
evaluation.	O
Blood	O
work	O
was	O
checked,	O
and	O
pt	O
received	O
amoxicillin	O
500	O
mg	O
PO,	O
and	O
was	O
cleared	O
for	O
procedure.	O
After	O
procedure,	O
she	O
went	O
for	O
a	O
walk	O
in	O
the	O
son,	O
had	O
lunch,	O
and	O
90	O
minutes	O
later	O
had	O
nonbloody	O
emesis	O
that	O
appeared	O
similar	O
to	O
her	O
lunch.	O
Her	O
temp	O
began	O
to	O
increase,	O
and	O
peaked	O
at	O
101.	O
She	O
presented	O
to	O
the	O
ED	O
given	O
multiple	O
instructions	O
in	O
the	O
past	O
to	O
seek	O
medical	O
care	O
for	O
temp>100	O
in	O
the	O
setting	O
of	O
her	O
myelodysplastic	O
disorder.	O
She	O
endorses	O
transient	O
___	O
frontal	O
headache	O
which	O
has	O
now	O
resolved,	O
denies	O
fevers,	O
chills,	O
chest	O
pain,	O
cough,	O
SOB,	O
rhinorrhea,	O
diarrhea.	O
She	O
denies	O
pain	O
at	O
dental	O
procedure	O
site.	O
Per	O
Dr.	O
___:	O
the	O
pt	O
has	O
"a	O
form	O
of	O
inherited	O
thrombocytopenia	O
known	O
as	O
dysmegakaryopoiesis	O
of	O
familial	O
platelet	O
disorder/AML.	O
This	O
was	O
first	O
described	O
in	O
___	O
and	O
is	O
exceedingly	O
rare	O
and	O
is	O
an	O
autosomal	O
dominant	O
disorder	O
that	O
is	O
characterized	O
by	O
thrombocytopenia	O
with	O
a	O
propensity	O
to	O
develop	O
myelodysplastic	O
syndromes	O
and/or	O
AML."	O
In	O
the	O
___	O
ED:	O
97.7	O
Tm	O
99.1,	O
112->187/90->126/66,	O
99%	O
RA	O
Labs	O
notable	O
for	O
baseline	O
leukopenia	O
and	O
thrombocytopenia	O
Per	O
ED	O
___,	O
spoke	O
with	O
Dr.	O
___	O
-	O
___,	O
admit	O
to	O
___	O
service	O
Received	O
zosyn,	O
1L	O
NS	O
BCx	O
sent	O
ROS:	O
All	O
else	O
negative	O
Past	O
Medical	O
History:	O
1.	O
Chronic	O
thrombocytopenia	O
with	O
a	O
germline	O
RUNX1	O
mutation	O
noted	O
in	O
___.	O
2.	O
Hypertension.	O
3.	O
Cesarean	O
section	O
with	O
hemorrhage	O
requiring	O
blood	O
and	O
platelets	O
in	O
___.	O
4.	O
Gastroesophageal	O
reflux.	O
5.	O
Hysterectomy	O
in	O
the	O
1990s	O
that	O
necessitated	O
blood	O
products.	O
6.	O
Uterine	O
fibroids.	O
7.	O
A	O
right	O
upper	O
quadrant	O
cyst	O
to	O
the	O
liver,	O
reported	O
stable	O
by	O
ultrasound	O
and	O
CT.	O
8.	O
Gallbladder	O
removal.	O
9.	O
A	O
malignant	O
polyp	O
removed	O
from	O
the	O
colon.	O
PRIOR	O
NOTES	O
REFER	O
TO:	O
"Significant	O
bipolar	O
disorder,	O
requiring	O
multiple	O
psych	O
admissions	O
through	O
her	O
lifetime."	O
THIS	O
IS	O
A	O
CHARTING	O
ERROR,	O
AND	O
REFERS	O
TO	O
HER	O
FATHER,	O
AND	O
NOT	O
TO	O
HER.	O
SHE	O
HAS	O
NO	O
PSYCHIATRIC	O
HISTORY.	O
Social	O
History:	O
___	O
Family	O
History:	O
Son	O
___	O
has	O
RUNX1	O
mutation	O
and	O
thrombocytopenia	O
Physical	O
Exam:	O
Exam	O
on	O
admission	O
--	O
unchanged	O
at	O
discharge	O
VS:	O
98.4,	O
144/80,	O
87,	O
99%	O
RA	O
Gen:	O
Very	O
pleasant	O
female	O
lying	O
in	O
bed,	O
NAD	O
HEENT:	O
PERRL,	O
EOMI,	O
slightly	O
raised	O
erythematous	O
rash	O
over	O
bilateral	O
cheeks.	O
Oropharynx	O
with	O
multiple	O
fillings	O
and	O
caps,	O
no	O
notable	O
erythema	O
or	O
drainage	O
at	O
site	O
of	O
procedure,	O
no	O
lesions	O
Neck:	O
supple,	O
no	O
cervical	O
or	O
supraclavicular	O
adenopathy	O
CV:	O
RRR,	O
no	O
m/r/g	O
Lungs:	O
CTAB,	O
no	O
wheeze	O
or	O
rhonchi	O
Abd:	O
soft,	O
nontender,	O
nondistended,	O
no	O
rebound	O
or	O
guarding,	O
palpable	O
liver	O
edge	O
2-3	O
cm	O
below	O
costal	O
margin,	O
nontender	O
GU:	O
no	O
foley	O
Ext:	O
WWP,	O
no	O
c/c/e	O
Neuro:	O
grossly	O
intact	O
Pertinent	O
Results:	O
Labs	O
on	O
admission:	O
___	O
06:35PM	O
LACTATE-1.1	O
___	O
06:30PM	O
GLUCOSE-119*	O
UREA	O
N-15	O
CREAT-0.7	O
SODIUM-136	O
POTASSIUM-3.7	O
CHLORIDE-97	O
TOTAL	O
CO2-27	O
ANION	O
GAP-16	O
___	O
06:30PM	O
estGFR-Using	O
this	O
___	O
06:30PM	O
URINE	O
HOURS-RANDOM	O
___	O
06:30PM	O
URINE	O
HOURS-RANDOM	O
___	O
06:30PM	O
URINE	O
UHOLD-HOLD	O
___	O
06:30PM	O
URINE	O
GR	O
HOLD-HOLD	O
___	O
06:30PM	O
WBC-2.2*	O
RBC-3.35*	O
HGB-10.0*	O
HCT-32.4*	O
MCV-97	O
MCH-29.9	O
MCHC-30.9*	O
RDW-24.2*	O
RDWSD-84.4*	O
___	O
06:30PM	O
NEUTS-82*	O
BANDS-0	O
LYMPHS-5*	O
MONOS-13	O
EOS-0	O
BASOS-0	O
___	O
MYELOS-0	O
AbsNeut-1.80	O
AbsLymp-0.11*	O
AbsMono-0.29	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
___	O
06:30PM	O
PLT	O
SMR-VERY	O
LOW	O
PLT	O
COUNT-69*	O
___	O
06:30PM	O
URINE	O
COLOR-Straw	O
APPEAR-Clear	O
SP	O
___	O
___	O
06:30PM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-TR	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-8.0	O
LEUK-NEG	O
___	O
06:30PM	O
URINE	O
RBC-3*	O
WBC-1	O
BACTERIA-FEW	O
YEAST-NONE	O
EPI-1	O
___	O
08:40AM	O
WBC-2.4*	O
RBC-3.44*	O
HGB-10.2*	O
HCT-33.5*	O
MCV-97	O
MCH-29.7	O
MCHC-30.4*	O
RDW-24.6*	O
RDWSD-85.5*	O
___	O
08:40AM	O
NEUTS-46.0	O
___	O
MONOS-23.8*	O
EOS-0.0*	O
BASOS-0.0	O
IM	O
___	O
AbsNeut-1.10*	O
AbsLymp-0.69*	O
AbsMono-0.57	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
___	O
08:40AM	O
HYPOCHROM-1+	O
ANISOCYT-2+	O
POIKILOCY-2+	O
MACROCYT-NORMAL	O
MICROCYT-NORMAL	O
POLYCHROM-2+	O
OVALOCYT-2+	O
SCHISTOCY-1+	O
TEARDROP-1+	O
ENVELOP-OCCASIONAL	O
___	O
08:40AM	O
PLT	O
SMR-VERY	O
LOW	O
PLT	O
COUNT-77*	O
Labs	O
on	O
discharge:	O
___	O
06:27AM	O
BLOOD	O
WBC-2.4*	O
RBC-3.10*	O
Hgb-9.1*	O
Hct-29.5*	O
MCV-95	O
MCH-29.4	O
MCHC-30.8*	O
RDW-23.9*	O
RDWSD-81.7*	O
Plt	O
Ct-63*	O
___	O
06:27AM	O
BLOOD	O
Neuts-70	O
Bands-0	O
Lymphs-14*	O
Monos-16*	O
Eos-0	O
Baso-0	O
___	O
Myelos-0	O
AbsNeut-1.68	O
AbsLymp-0.34*	O
AbsMono-0.38	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
Imaging:	O
CXR	O
-	O
clear	O
lungs,	O
hyperinflation	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
hx	O
of	O
a	O
rare	O
myelodysplastic	O
disorder	O
followed	O
by	O
Dr.	O
___	O
presenting	O
with	O
fever	O
after	O
dental	O
procedure,	O
concerning	O
for	O
procedure-related	O
bacteremia.	O
#	O
Fever:	O
Tmax	O
in	O
ED	O
99.1,	O
at	O
home	O
as	O
high	O
as	O
101.	O
ANC	O
at	O
___	O
on	O
___	O
was	O
<500,	O
but	O
while	O
here	O
ranged	O
1100-1800.	O
No	O
localizing	O
symptoms	O
other	O
than	O
rash.	O
Per	O
Dr.	O
___,	O
appropriate	O
to	O
cover	O
broadly	O
as	O
if	O
neutropenic.	O
Received	O
zosyn	O
in	O
ED,	O
but	O
changed	O
to	O
Unasyn/cipro	O
for	O
low	O
risk	O
F&N	O
coverage,	O
transitioned	O
to	O
Augmentin/Cipro	O
at	O
discharge	O
for	O
total	O
of	O
10	O
day	O
course.	O
UA/cx,	O
BCx,	O
CXR	O
unremarkable.	O
#	O
Rash:	O
mild,	O
facial	O
rash	O
after	O
taking	O
amoxicillin	O
in	O
the	O
sun.	O
Would	O
consider	O
cause	O
being	O
amoxicillin,	O
but	O
since	O
tolerating	O
amp/sulbactam,	O
doubt	O
this	O
is	O
a	O
penicillin	O
allergy.	O
In	O
order	O
to	O
avoid	O
too	O
broad	O
___	O
(and	O
history	O
of	O
sulfa	O
allergy)	O
and	O
allowing	O
for	O
a	O
reasonable	O
po	O
transition,	O
continued	O
with	O
amp/sulbactam.	O
No	O
e/o	O
DRESS	O
or	O
SJS.	O
She	O
was	O
encouraged	O
to	O
avoid	O
sun	O
exposure	O
while	O
on	O
antibiotics.	O
#	O
Thrombocytopenia:	O
Chronic,	O
at	O
baseline.	O
Remained	O
stable.	O
#	O
Hypertension:	O
Continued	O
home	O
Losartan.	O
Billing:	O
>30	O
minutes	O
spent	O
coordinating	O
discharge	O
to	O
home	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Losartan	O
Potassium	O
75	O
mg	O
PO	O
QHS	O
2.	O
Losartan	O
Potassium	O
25	O
mg	O
PO	O
QAM	O
Discharge	O
Medications:	O
1.	O
Losartan	O
Potassium	O
75	O
mg	O
PO	O
QHS	O
2.	O
Losartan	O
Potassium	O
25	O
mg	O
PO	O
QAM	O
3.	O
Ciprofloxacin	O
HCl	O
500	O
mg	O
PO/NG	O
Q12H	O
RX	O
*ciprofloxacin	O
HCl	O
[Cipro]	O
500	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*16	O
Tablet	O
Refills:*0	O
4.	O
Amoxicillin-Clavulanic	O
Acid	O
___	O
mg	O
PO	O
Q8H	O
Duration:	O
8	O
Days	O
RX	O
*amoxicillin-pot	O
clavulanate	O
500	O
mg-125	O
mg	O
1	O
tab	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*24	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Fever	O
Functional	O
neutropenia	O
Dysmegakaryopoiesis	O
of	O
familial	O
platelet	O
disorder/AML	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
for	O
fever	O
along	O
with	O
your	O
blood	O
disorder.	O
For	O
this	O
you	O
were	O
treated	O
with	O
strong	O
antibiotics,	O
which	O
you	O
will	O
continue	O
to	O
complete	O
total	O
of	O
10	O
day	O
course	O
(8	O
more	O
days).	O
Followup	O
Instructions:	O
___	O

